
PrEP in Thailand
What is PrEP? A game changer for HIV prevention strategies, PrEP, or pre-exposure prophylaxis, is a medicine that people who do not have HIV can take…
Read article →LOVE FOUNDATION BLOG
Published articles from our original WordPress archive, organised for easier discovery.

What is PrEP? A game changer for HIV prevention strategies, PrEP, or pre-exposure prophylaxis, is a medicine that people who do not have HIV can take…
Read article →
Sunlenca treats HIV with other medicines; Yeztugo is US-approved lenacapavir PrEP. Review evidence, use, monitoring, and access in Thailand.
Read article →
Today, as Chiang Mai becomes an appealing destination for business conferences and tourism, health awareness and care matter for both visitors and locals.
Read article →
Condoms are not just a method of birth control; they are a cornerstone of sexual health that serves several important purposes.
Read article →
Taking PrEP is currently the most effective way to prevent HIV infection. When you take PrEP, it helps reduce...
Read article →
PEP (post-exposure prophylaxis) is one of the newer ways to prevent HIV, meant only for people facing an emergency risk, such as a broken condom.
Read article →
2-1-1 PrEP uses oral TDF/FTC before and after sex on a defined schedule. Evidence is limited to adult cisgender men who have sex with men and can plan sex…
Read article →
PrEP is used before possible HIV exposure; PEP is used after an emergency exposure. Both are for people who do not have HIV, but their dosing, tests…
Read article →
Long-acting injectable cabotegravir is a highly effective PrEP option for people who prefer not to take daily tablets.
Read article →
PrEP protects you from HIV infection by using antiretroviral medication in people at risk before they are exposed to the virus.
Read article →
PEP (Post-Exposure Prophylaxis) is an emergency course of antiretroviral medicine for people who do not have HIV and want to prevent infection after…
Read article →
PrEP is highly effective when used as prescribed, reducing sexual HIV acquisition risk by about 99% and risk from injection drug use by at least about 74%.
Read article →